Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction

Published:2021-03 Issue:3 Volume:27 Page:309-317
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Ghuman Jasleen^ORCID,Cai Xuan,Patel Ravi B.,Khan Sadiya S.,Hecktman Jonathan,Redfield Margaret M.,Lewis Gregory,Shah Sanjiv J.,Wolf Myles,Isakova Tamara,Mehta Rupal

Funder

National Kidney Foundation of Illinois

National Institutes of Health

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Heart disease and stroke statistics-2019 Update: a report from the American Heart Association;Benjamin;Circulation,2019

2. Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction;Tsao;JACC Heart Fail,2018

3. Heart failure with preserved ejection fraction;Redfield;N Engl J Med,2017

4. Exercise ventilatory efficiency in older and younger heart failure patients with preserved ejection fraction;Smith;J Cardiac Fail,2019

5. Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training;Swank;Circ Heart Fail,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Rehabilitation Increases Plasma Klotho Levels;Journal of Clinical Medicine;2024-03-14

2. Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO2 study;Frontiers in Cardiovascular Medicine;2023-08-25

3. FGF23 and klotho at the intersection of kidney and cardiovascular disease;Nature Reviews Cardiology;2023-07-13

4. Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease;Kidney and Blood Pressure Research;2023

5. FGF23 and Cardiovascular Structure and Function in Advanced Chronic Kidney Disease;Kidney360;2022-09-29